Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
< Previous
1
2
3
4
5
6
7
8
Next >
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
December 13, 2021
Tickers
ALXO
Tags
Trading Ideas
Health Care
Phase 2 Trial
From
Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
December 13, 2021
Tickers
VIRX
Tags
Trading Ideas
Penny Stocks
Health Care
From
Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
December 13, 2021
Tickers
HARP
Tags
Trading Ideas
Health Care
Phase 2 Trial
From
Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
Tickers
JNJ
LEGN
Tags
JNJ
Health Care
multiple myeloma
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
RHHVF
Health Care
From
Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
Tags
BLUE
Market News
gene therapy
From
Benzinga
Arvinas, Pfizer's ARV-471 Shows Clinical Benefit Rate Of 40% In Pretreated Breast Cancer Patients
December 10, 2021
Tickers
ARVN
PFE
Tags
Briefs
Phase 1 Trial
News
From
Benzinga
Moderna Posts Data From Early mRNA Flu Vaccine Study, Pivotal Trial On Its Way
December 10, 2021
Tickers
BNTX
MRNA
SNY
Tags
influenza
Market News
Biotech
From
Benzinga
AbbVie, SpringWorks Join Forces To Conduct Multiple Myeloma Combo Therapy Trial
December 10, 2021
Tickers
ABBV
SWTX
Tags
Biotech
Market News
SWTX
From
Benzinga
Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise
December 09, 2021
Tickers
FREQ
Tags
Trading Ideas
Health Care
General
From
Benzinga
Ambrx Biopharma Shares Jump After Safety, Efficacy Data From Breast Cancer Trial
December 09, 2021
Tickers
AMAM
Tags
Market News
Biotech
why it's moving
From
Benzinga
Ideaya Reports New Data From Combo Therapy Regime In Pretreated Eye Cancer Patients
December 07, 2021
Tickers
IDYA
Tags
Phase 2 Trial
General
Small Cap
From
Benzinga
Prometheus Biosciences Posts Phase 1 Data On Lead Therapeutic Candidate
December 07, 2021
Tickers
RXDX
Tags
Benzinga
News
Phase 1 Trial
From
Benzinga
Inventiva Posts Results of Clinical Thorough QT Study Of Lanifibranor
December 07, 2021
Tickers
IVA
Tags
General
Small Cap
Health Care
From
Benzinga
Adagene's Posts Early Safety, Efficacy Data From Cold Tumors Trial
December 07, 2021
Tickers
ADAG
Tags
Health Care
Trading Ideas
Movers
From
Benzinga
Bellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studies
December 06, 2021
Tickers
BLCM
Tags
Penny Stocks
Health Care
Offerings
From
Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
December 06, 2021
Tickers
IMCR
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Health Care
RHHBY
From
Benzinga
Adicet Stock Rallies After Early Responses For Off-The-Shelf Drug In B-cell Non-Hodgkin's Lymphoma
December 06, 2021
Tickers
ACET
Tags
ACET
Market News
Biotech
From
Benzinga
Fulcrum Therapeutics Shares Additional Data From Phase 1 Trial Of Sickle Cell Disease Treatment
December 06, 2021
Tickers
FULC
Tags
Small Cap
General
Movers
From
Benzinga
Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate
December 06, 2021
Tickers
BOLT
Tags
BOLT
Market News
Biotech
From
Benzinga
Molecular Partners' Ensovibep Shows Early Safety Profile In COVID-19
December 06, 2021
Tickers
MOLN
Tags
Benzinga
News
Phase 1 Trial
From
Benzinga
Stoke Touts Early Signs Of Efficacy For Antisense Drug In Dravet Syndrome
December 03, 2021
Tickers
STOK
Tags
Trading Ideas
epilepsy
Health Care
From
Benzinga
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
December 02, 2021
Tickers
SQZ
Tags
Movers
Small Cap
General
From
Benzinga
Inhibrx Precision Cancer Antibody Receives FDA Orphan Drug Tag For Rare Bone Cancer
December 02, 2021
Tickers
INBX
Tags
Biotech
Market News
INBX
From
Benzinga
Read Why Is Roth Capital Bullish On This Cancer-Focused Stock
December 01, 2021
Tickers
MBRX
Tags
MBRX
Biotechnology
Briefs
From
Benzinga
Arbutus' Hepatitis B Candidate Shows Encouraging Antiviral Activity
December 01, 2021
Tickers
ABUS
MRNA
Tags
hepatitis B
Movers
MRNA
From
Benzinga
Mereo BioPharma's Etigilimab/Opdivo Combo Achieves One Complete Response In Cervical Cancer
November 30, 2021
Tickers
BMY
MREO
Tags
Benzinga
Solid Tumor
Phase 1 Trial
From
Benzinga
After Denying Data Leak, Olema Shares First Data For Lead Program In Breast Cancer Patients
November 30, 2021
Tickers
OLMA
Tags
Trading Ideas
Health Care
breast cancer
From
Benzinga
EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa
November 30, 2021
Tickers
HOTH
Tags
Market News
Biotech
HOTH
From
Benzinga
Adagene Shares Jump After FDA Signs Off ADG116/Keytruda Combo Therapy Trial In Solid Tumors
November 30, 2021
Tickers
ADAG
MRK
Tags
Trading Ideas
Health Care
Small Cap
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.